An economic evaluation of the costs of α-interferon treatment of chronic active hepatitis due to hepatitis B or C virus
- 1 January 1990
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 11, S11-S18
- https://doi.org/10.1016/0168-8278(90)90157-m
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Interferon in viral hepatitis: Role in pathogenesis and treatmentHepatology, 1986
- Survival and prognostic indicators in compensated and decompensated cirrhosisDigestive Diseases and Sciences, 1986
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1983
- Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.Gut, 1982